Peer-reviewed veterinary case report
Genetic Variants on Dog Chromosome 12 Linked to Nail Disease
By Gershony, Liza C et al.·Published in Genes·2021·Department on Animal Science, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Whole Genome Sequencing Reveals Multiple Linked Genetic Variants on Canine Chromosome 12 Associated with Risk for Symmetrical Lupoid Onychodystrophy (SLO) in the Bearded Collie.
- Species:
- dog
Plain-English summary
A Bearded Collie with symmetrical lupoid onychodystrophy (SLO) was found to have nail loss and abnormal claw regrowth, which is linked to an autoimmune response. Researchers discovered specific genetic variants on chromosome 12 that are associated with an increased risk of SLO in this breed. While no direct protein-coding variants were identified, many of the variants could potentially harm the dog's health and are correlated with certain genetic markers. Understanding these genetic links may help breeders reduce the chances of SLO in future generations of Bearded Collies.
People also search for: Bearded Collie nail loss treatment · dog autoimmune disease symptoms · SLO in dogs genetics
Abstract
In dogs, symmetrical lupoid onychodystrophy (SLO) results in nail loss and an abnormal regrowth of the claws. In Bearded Collies, an autoimmune nature has been suggested because certain dog leukocyte antigen (DLA) class II haplotypes are associated with the condition. A genome-wide association study of the Bearded Collie revealed two regions of association that conferred risk for disease: one on canine chromosome (CFA) 12 that encompasses the DLA genes, and one on CFA17. Case-control association was employed on whole genome sequencing data to uncover putative causative variants in SLO within the CFA12 and CFA17 associated regions. Genotype imputation was then employed to refine variants of interest. Although no SLO-associated protein-coding variants were identified on CFA17, multiple variants, many with predicted damaging effects, were identified within potential candidate genes on CFA12. Furthermore, many potentially damaging alleles were fully correlated with the presence of DLA class II risk haplotypes for SLO, suggesting that the variants may reflect DLA class II haplotype association with disease or vice versa. Strong linkage disequilibrium in the region precluded the ability to isolate and assess the individual or combined effect of variants on disease development. Nonetheless, all were predictive of risk for SLO and, with judicious assessment, their application in selective breeding may prove useful to reduce the incidence of SLO in the breed.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/34440439/